Disclosures for "Efficacy and safety of different doses of subcutaneous galcanezumab in chronic and episodic migraine: A pooled analysis of 3651 patients")
-
Mohamed Sayed Zaazouee has nothing to disclose.
-
Mr. Elsnhory has nothing to disclose.
-
Ms. Ebrahim has nothing to disclose.
-
Dr. Alaraj has nothing to disclose.
-
Dr. Saad has nothing to disclose.
-
Dr. Zaki has nothing to disclose.
-
Mr. Ali has nothing to disclose.
-
Dr. Fahmy Fawy has nothing to disclose.
-
Dr. Ahmed has nothing to disclose.
-
Dr. Elshennawy has nothing to disclose.
-
Dr. Eleyan has nothing to disclose.
-
Dr. Alahmad has nothing to disclose.
-
Dr. Abo Hamra has nothing to disclose.
-
Dr. AbuEl-Enien has nothing to disclose.
-
Dr. Elromely has nothing to disclose.
-
Dr. Elshanbary has nothing to disclose.